Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Outdo Biotech is a leading Chinese biotechnology company specializing in biobanking, tissue microarrays (TMAs), and precision medicine services. Founded in 2003 and headquartered in Shanghai, the company operates one of China's largest clinical sample libraries, housing over 500,000 samples to support high-throughput biomarker validation and companion diagnostic (CDx) development. Outdo Biotech provides a comprehensive suite of services including immunohistochemistry (IHC), digital pathology, and genomic analysis for global pharmaceutical and academic partners. The company plays a pivotal role in oncology research, particularly in the validation of diagnostic antibodies and the discovery of novel therapeutic targets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Outdo Biotech.